EvokAI Creative Labs Inc.

Equities

OKAI

CA30053J1012

Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 09:30:00 2024-04-22 am EDT			5-day change	1st Jan Change
0.13 ^CAD	0.00%		0.00%	+73.33%

2023	EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	EvokAI Creative Labs Inc. Receives Ce Mark Approval for Its Mdm Flex Sensor to Transform the Management of Parkinson's Disease	CI

EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023

November 29, 2023 at 01:51 pm EST

EvokAI Creative Labs Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.012767 million. Net loss was USD 0.69542 million compared to USD 0.124564 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.012767 million. Net loss was USD 4.86 million compared to USD 0.314259 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.02 a year ago.

Latest news about EvokAI Creative Labs Inc.

EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
EvokAI Creative Labs Inc. Receives Ce Mark Approval for Its Mdm Flex Sensor to Transform the Management of Parkinson's Disease	23-10-30	CI
EvokAI Creative Labs Inc. completed the acquisition of Rehaboo Oy.	23-06-22	CI
EvokAI Creative Labs Closes Acquisition of Extended Reality AI-Powered Company Neurocarrier Oy	23-06-16	MT
EvokAI Creative Labs Inc. completed the acquisition of NeuroCarrier Oy.	23-06-14	CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire NeuroCarrier Oy.	23-05-31	CI
EvokAI Creative Labs Inc. completed the acquisition of Head Instruments Oy.	23-05-28	CI
EvokAI Creative Labs Inc. entered into a Share Purchase Agreement to acquire Rehaboo Oy for $4 million.	23-05-10	CI
EvokAI Creative Labs Inc. Auditor Raises 'Going Concern' Doubt	23-04-26	CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire Head Instruments Oy for â‚¬4.4 million.	23-04-23	CI
EvokAI Creative Labs Inc. acquired Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction	23-04-10	CI
Sebastiani Ventures Corp. Announces Board Appointments	22-12-21	CI
Sebastiani Ventures Corp. Appoints Alejandro Antalich as Chief Executive Officer	22-12-21	CI
EvokAI Creative Labs Inc. announced that it has received CAD 5 million in funding from Sebastiani Ventures Corp.	22-12-21	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08	CI
EvokAI Creative Labs Inc. announced that it expects to receive CAD 5 million in funding from Sebastiani Ventures Corp.	22-08-16	CI
EvokAI Creative Labs Inc. entered into a binding letter of intent to acquire Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction.	22-08-16	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-27	CI
Sebastiani Ventures Corp. announced that it has received CAD 0.25 million in funding	22-05-31	CI
EvokAI Creative Labs Inc. acquired 96% stake in Advancience Ltd from Baden Resources Limited for $2.05 million.	22-05-24	CI
Sebastiani Ventures Corp. announced that it expects to receive CAD 0.25 million in funding	22-05-18	CI
Sebastiani Ventures Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-05	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Sebastiani Ventures Corp. Auditor Raises 'Going Concern' Doubt	22-04-07	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-17	CI

Chart EvokAI Creative Labs Inc.

Duration

Period

More charts

Company Profile

EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Software & Technology Services

	1st Jan change	Capi.
EVOKAI CREATIVE LABS INC.	+73.33%	7.22M
VEEVA SYSTEMS INC.	+4.46%	32.47B
PRO MEDICUS LIMITED	+16.51%	7.45B
SECTRA AB	+23.49%	3.89B
EVOLENT HEALTH, INC.	-15.83%	3.17B
OMNICELL, INC.	-26.79%	1.28B
LUNIT INC.	-33.58%	1.09B
B-SOFT CO.,LTD.	-33.74%	902M
SIMULATIONS PLUS, INC.	+1.34%	893M
VERADIGM INC.	-25.64%	857M

Medical Software & Technology Services